May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Trends in Indications for Penetrating Keratoplasty in the Academic Setting (2002-2007)
Author Affiliations & Notes
  • W. B. Brothers
    Ophthalmology, St Louis University, St Louis, Missouri
  • H. Hsu
    Ophthalmology, St Louis University, St Louis, Missouri
  • Footnotes
    Commercial Relationships  W.B. Brothers, None; H. Hsu, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 1976. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      W. B. Brothers, H. Hsu; Trends in Indications for Penetrating Keratoplasty in the Academic Setting (2002-2007). Invest. Ophthalmol. Vis. Sci. 2008;49(13):1976. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To study the leading indications and changing trends for penetrating keratoplasty (PK) in our academic setting over the last 5 years.

Methods: : A retrospective review of the indications for PKs performed at St Louis University during the years of 2002-2007.

Results: : During our study from 2002-2007, 94 PKs were performed. Regraft (39.3%) was the leading indication for PK, followed by pseudophakic bullous keratopathy (PBK)/aphakic bullous keratopathy (ABK) (30.0%), keratoconus (KCN) and other ectasias (7.4%), corneal scar (11.6 %), and Fuchs dystrophy (8.5%).

Conclusions: : In our study, regraft was noted to be the leading indication for PK at our institution. This was unlike previously published data from the Eye bank Association (2002-2007) which supported PBK/ABK as the leading indication at 21.1% followed by KCN(14.8%), Fuch’s (13.8%), and lastly regraft (12%).

Keywords: cornea: clinical science • clinical (human) or epidemiologic studies: prevalence/incidence • clinical (human) or epidemiologic studies: risk factor assessment 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×